TRACEY MORRAN: Open Payments
NPI 1972087542 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 116 payments from 15 companies in 2025. Trend: 2023 $1,427 · 2024 $1,481 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $575 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $268 |
| Janssen Biotech, Inc. | 16 | $267 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $183 |
| PFIZER INC. | 7 | $175 |
| Phathom Pharmaceuticals, Inc. | 6 | $173 |
| Aimmune Therapeutics, Inc. | 8 | $149 |
| Madrigal Pharmaceuticals | 7 | $127 |
| Lilly USA, LLC | 3 | $76 |
| Ferring Pharmaceuticals Inc. | 2 | $68 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, XIFAXAN, VOQUEZNA, RINVOQ, LINZESS, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
